tiprankstipranks
Advertisement
Advertisement

INMB Stock Latest News

Inmune Bio Shareholders Reaffirm Board, Auditor and Incentive Plan
Company AnnouncementsInmune Bio Shareholders Reaffirm Board, Auditor and Incentive Plan
4d ago
8K
INMB
Maintained Buy on INmune Bio as Compelling Phase 2 Alzheimer’s Data Support XPro1595; $8 Price Target Reiterated
PremiumRatings
Maintained Buy on INmune Bio as Compelling Phase 2 Alzheimer’s Data Support XPro1595; $8 Price Target Reiterated
18d ago
INMB
INmune Bio reports positive Phase 2 MRI results
PremiumCompany Announcements
INmune Bio reports positive Phase 2 MRI results
19d ago
8K
INMB
INmune Bio reports positive MRI data in Phase 2 Alzheimer’s trial
PremiumThe Fly
INmune Bio reports positive MRI data in Phase 2 Alzheimer’s trial
19d ago
INMB
Inmune Bio Charts Regulatory Path Amid Cash Constraints
PremiumCompany Announcements
Inmune Bio Charts Regulatory Path Amid Cash Constraints
1M ago
INMB
INmune Bio publishes MINDFuL trial results in NPJ Dementia
PremiumThe FlyINmune Bio publishes MINDFuL trial results in NPJ Dementia
1M ago
INMB
INmune Bio Receives FDA Fast Track for XPro
Premium
Company Announcements
INmune Bio Receives FDA Fast Track for XPro
1M ago
8K
INMB
INmune Bio receives fast track designation from FDA for XPro
Premium
The Fly
INmune Bio receives fast track designation from FDA for XPro
1M ago
INMB
Inmune Bio Advances CORDStrom Amid Funding Pressures
PremiumCompany Announcements
Inmune Bio Advances CORDStrom Amid Funding Pressures
1M ago
INMB
INmune Bio Expands Cord Tissue License for CORDStrom Platform
PremiumCompany Announcements
INmune Bio Expands Cord Tissue License for CORDStrom Platform
2M ago
8K
INMB
INmune Bio announces new preclinical data for INB03
PremiumThe Fly
INmune Bio announces new preclinical data for INB03
2M ago
INMB
Inmune Bio Earnings Call Balances Progress and Risk
PremiumCompany Announcements
Inmune Bio Earnings Call Balances Progress and Risk
3M ago
INMB
INMB Upcoming Earnings Report: What to Expect?
PremiumPre-EarningsINMB Upcoming Earnings Report: What to Expect?
3M ago
INMB
INmune Bio’s MINDFuL trial presented as succesful example in Alzheimer’s
Premium
The Fly
INmune Bio’s MINDFuL trial presented as succesful example in Alzheimer’s
3M ago
INMB
INmune Bio upgraded to Buy from Neutral at Lucid Capital
Premium
The Fly
INmune Bio upgraded to Buy from Neutral at Lucid Capital
3M ago
INMB
Inmune Bio Completes Early INKmune Trial in Advanced Prostate Cancer: What Investors Should Watch Next
PremiumCompany Announcements
Inmune Bio Completes Early INKmune Trial in Advanced Prostate Cancer: What Investors Should Watch Next
4M ago
INMB
INmune Bio Highlights CORDStrom RDEB Program and IP Strength
PremiumCompany Announcements
INmune Bio Highlights CORDStrom RDEB Program and IP Strength
4M ago
8K
INMB
INmune Bio Advances XPro Toward Registrational Alzheimer’s Study
PremiumCompany Announcements
INmune Bio Advances XPro Toward Registrational Alzheimer’s Study
4M ago
8K
INMB
INmune Bio to Present New CORDStrom Phase III Data
PremiumCompany Announcements
INmune Bio to Present New CORDStrom Phase III Data
4M ago
8K
INMB
INmune Bio Advances CORDStrom Toward Rare Disease Commercialization
PremiumCompany AnnouncementsINmune Bio Advances CORDStrom Toward Rare Disease Commercialization
4M ago
8K
INMB
INmune Bio: Biomarker-Driven Alzheimer’s Trial Design and Pipeline Catalysts Underpin Buy Rating
Premium
Ratings
INmune Bio: Biomarker-Driven Alzheimer’s Trial Design and Pipeline Catalysts Underpin Buy Rating
4M ago
INMB
INmune Bio announces FDA alignment on phase 2b/3 registration pathway
Premium
The Fly
INmune Bio announces FDA alignment on phase 2b/3 registration pathway
4M ago
INMB

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >